glp-1 employer coverage news october 2025 43% of large companies cover in health plans : r/Zepbound employer coverage glp-1 news october

FDA has aligned with OKYO Pharma on the design of the NEPTUNE Phase 3 clinical trial evaluating urcosimod for neuropathic corneal pain (NCP)

, ,

As noted in Ozempics official safety information: "Stop using Ozempic and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat

It can cause redness, flakiness, and peeling, particularly when first introduced to a skincare routine or when used in high concentrations

It directly stimulates pro-opiomelanocortin/cocaine-and-amphetamine-regulated transcript (POMC/CART) neurons and indirectly inhibits neuropeptide-Y/agouti-related protein (NPY/AgRP) neurons through GABA neurotransmission, reducing appetite and promoting weight loss [40]